Stocks · Health care · Pharmaceutical Preparations

ARDELYX, INC.

ARDX Clue Score52
United States Fiscal year ends December CIK 0001437402
$3.28 +0.31% Close, 9 Oct 2026
Price $3.28 +154.26% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−112.9Net income−112.4Fiscal year 2017Revenue42.0Operating income−65.1Net income−64.3Fiscal year 2018Revenue2.6 −93.8%Operating income−90.9Net income−91.3Fiscal year 2019Revenue5.3 +102.6%Operating income−91.3Net income−94.9EPS, diluted−1.47Fiscal year 2020Revenue7.6 +43.4%Operating income−90.8Net income−94.3EPS, diluted−1.05Fiscal year 2021Revenue10.1 +33.4%Operating income−154.3Net income−158.2EPS, diluted−1.52Fiscal year 2022Revenue52.2 +416.6%Operating income−63.8Net income−67.2EPS, diluted−0.42Fiscal year 2023Revenue124.5 +138.6%Operating income−63.3Net income−66.1EPS, diluted−0.30Fiscal year 2024Revenue333.6 +168.1%Operating income−28.0Net income−39.1EPS, diluted−0.17Fiscal year 2025Revenue407.3 +22.1%Operating income−41.0Net income−61.6EPS, diluted−0.26
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 42.0 2.6 5.3 7.6 10.1 52.2 124.5 333.6 407.3
Growth −93.8% +102.6% +43.4% +33.4% +416.6% +138.6% +168.1% +22.1%
Operating income −112.9 −65.1 −90.9 −91.3 −90.8 −154.3 −63.8 −63.3 −28.0 −41.0
Net income −112.4 −64.3 −91.3 −94.9 −94.3 −158.2 −67.2 −66.1 −39.1 −61.6
Growth
EPS, diluted n/a n/a n/a −1.47 −1.05 −1.52 −0.42 −0.30 −0.17 −0.26

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Gross margin80.0%Operating margin−155.0%Net margin−153.2%Free cash flow margin−160.8%Fiscal year 2018Gross margin82.1%Operating margin−3,488.6%Net margin−3,502.0%Free cash flow margin−2,707.5%Fiscal year 2019Gross margin88.6%Operating margin−1,728.1%Net margin−1,797.8%Free cash flow margin−1,454.4%Fiscal year 2020Operating margin−1,199.0%Net margin−1,245.7%Free cash flow margin−1,079.9%Fiscal year 2021Operating margin−1,528.6%Net margin−1,566.5%Free cash flow margin−1,529.3%Fiscal year 2022Operating margin−122.2%Net margin−128.9%Free cash flow margin−134.4%Fiscal year 2023Operating margin−50.8%Net margin−53.1%Free cash flow margin−72.4%Fiscal year 2024Operating margin−8.4%Net margin−11.7%Free cash flow margin−13.7%Fiscal year 2025Operating margin−10.1%Net margin−15.1%Free cash flow margin−10.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 80.0% 82.1% 88.6% n/a n/a n/a n/a n/a n/a
Operating margin n/a −155.0% −3,488.6% −1,728.1% −1,199.0% −1,528.6% −122.2% −50.8% −8.4% −10.1%
Net margin n/a −153.2% −3,502.0% −1,797.8% −1,245.7% −1,566.5% −128.9% −53.1% −11.7% −15.1%
Free cash flow margin n/a −160.8% −2,707.5% −1,454.4% −1,079.9% −1,529.3% −134.4% −72.4% −13.7% −10.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−92.5Capital expenditure−4.9Free cash flow−97.4Fiscal year 2017Operating cash flow−65.2Capital expenditure−2.4Free cash flow−67.5Fiscal year 2018Operating cash flow−70.3Capital expenditure−0.3Free cash flow−70.6Fiscal year 2019Operating cash flow−76.5Capital expenditure−0.3Free cash flow−76.8Fiscal year 2020Operating cash flow−81.4Capital expenditure−0.3Free cash flow−81.8Fiscal year 2021Operating cash flow−152.6Capital expenditure−1.9Free cash flow−154.4Fiscal year 2022Operating cash flow−70.0Capital expenditure−0.1Free cash flow−70.1Fiscal year 2023Operating cash flow−89.7Capital expenditure−0.3Free cash flow−90.1Fiscal year 2024Operating cash flow−44.8Capital expenditure−1.0Free cash flow−45.8Fiscal year 2025Operating cash flow−42.5Capital expenditure−1.5Free cash flow−44.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −92.5 −65.2 −70.3 −76.5 −81.4 −152.6 −70.0 −89.7 −44.8 −42.5
Capital expenditure −4.9 −2.4 −0.3 −0.3 −0.3 −1.9 −0.1 −0.3 −1.0 −1.5
Free cash flow −97.4 −67.5 −70.6 −76.8 −81.8 −154.4 −70.1 −90.1 −45.8 −44.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash74.6Shareholders’ equity193.2Fiscal year 2017Cash75.4Shareholders’ equity139.3Fiscal year 2018Cash78.8Total debt52.0Net cash (debt)26.8Shareholders’ equity115.8Debt to equity0.45Fiscal year 2019Cash181.1Total debt50.0Net cash (debt)131.1Shareholders’ equity186.7Debt to equity0.27Fiscal year 2020Cash91.0Total debt50.8Net cash (debt)40.2Shareholders’ equity126.1Debt to equity0.40Fiscal year 2021Cash72.4Total debt64.5Net cash (debt)7.9Shareholders’ equity82.6Debt to equity0.78Fiscal year 2022Cash96.1Total debt26.7Net cash (debt)69.4Shareholders’ equity98.3Debt to equity0.27Fiscal year 2023Cash21.5Total debt49.8Net cash (debt)−28.4Shareholders’ equity166.8Debt to equity0.30Fiscal year 2024Cash64.9Total debt150.9Net cash (debt)−85.9Shareholders’ equity173.3Debt to equity0.87Fiscal year 2025Cash68.0Total debt202.8Net cash (debt)−134.8Shareholders’ equity166.9Debt to equity1.21
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 74.6 75.4 78.8 181.1 91.0 72.4 96.1 21.5 64.9 68.0
Total debt n/a n/a 52.0 50.0 50.8 64.5 26.7 49.8 150.9 202.8
Net cash (debt) n/a n/a 26.8 131.1 40.2 7.9 69.4 −28.4 −85.9 −134.8
Shareholders’ equity 193.2 139.3 115.8 186.7 126.1 82.6 98.3 166.8 173.3 166.9
Debt to equity n/a n/a 0.45 0.27 0.40 0.78 0.27 0.30 0.87 1.21

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−92.5 −65.2 −70.3 −76.5 −81.4 −152.6 −70.0 −89.7 −44.8 −42.5
Growth
n/a n/a n/a n/a 2.5 2.8 1.1 1.3 2.1 3.1
Investment
−4.9 −2.4 −0.3 −0.3 −0.3 −1.9 −0.1 −0.3 −1.0 −1.5
calc −97.4 −67.5 −70.6 −76.8 −81.8 −154.4 −70.1 −90.1 −45.8 −44.0
Growth
calc n/a n/a n/a −1.19 −0.91 −1.48 −0.44 −0.41 −0.19 −0.18
−131.1 65.3 −29.9 23.4 −31.4 50.9 18.4 −131.2 −18.3 −9.0
Financing
191.2 0.7 103.6 155.5 22.8 83.0 75.3 146.3 106.6 54.5

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.